Find a Doctor
To find your closest EVO ICL doctor, start by searching your location.
3+ million lenses distributed worldwide

Sort by:
Office Information
Eye Consultants of Texas
Office Hours
- Today
- -
About this Doctor
A board certified ophthalmologist, Phillips Kirk Labor, MD, FACS, FICS, ABES is internationally recognized for his work in refractive surgery. He has over 30 years of refractive and cataract expertise, and has performed thousands of refractive procedures over his career. Dr. Labor’s board certification goes above and beyond, placing him among a very select group of U.S. eye surgeons.
In addition to standard certification by the American Board of Ophthalmology (ABO), he is certified by the American Board of Eye Surgery (ABES) in the field of refractive surgery. This requires more in-depth study, and passing a rigorous process of testing by his peers. In addition, ABES requires doctors to repeat this process regularly for re-certification, which Dr. Labor has achieved. Dr. Labor chose this voluntary certification to continue to grow his expertise in order to better serve his patients.
In addition, he has published numerous articles on a wide range of ophthalmic subjects and issues, and led or collaborated on key studies. This includes participating or serving as principal investigator in multiple clinical trials to obtain FDA approval for advanced intraocular lens implant technologies. He is also one of a select few U.S. eye surgeons manufacturers have chosen to evaluate new technologies.
Dr. Labor has received several honors for his outstanding work and expertise. For example, he has been voted a Tarrant County “Top Doctor” by his peers numerous times in Fort Worth, Texas magazine. He has consistently been voted a “Top Ophthalmologist” in Living Magazine’s readership polls. He has also been named one of “America’s Top Ophthalmologists” by the Consumers’ Research Council of America, and recognized by Premier Surgeon as one of the top 250 leading U.S. innovators for premium intraocular lens surgery.
In addition, Dr. Labor is actively involved in a leadership capacity with several notable eye care organizations. He is a past president of the Society for Excellence in Eyecare (SEE), an elected position based on his reputation as an ophthalmologist and eye surgeon, and continued contributions to SEE, and currently serves on its board. He also serves on the board of the American College of Eye Surgeons, and has remained an International College of Surgeons (ICS) U.S. Section Vice President since elected in 2013. He is a Fellow of the ICS, the American Academy of Ophthalmology, and the American Society of Cataract and Refractive Surgery, and a founding member of the American European Congress of Ophthalmic Surgeons. Dr. Labor is a member of the Refractive Surgery Alliance, an organization dedicated to the advancement of Refractive Surgery through education, research, management and patient care. Other professional associations include: International Society of Refractive Surgery, Southern Medical Association, Texas Ophthalmological Society, Texas Medical Association, Tarrant County Ophthalmological Society, and Tarrant County Medical Society.
In giving back, Dr. Labor is a volunteer ophthalmologist for EyeCare America, sponsored by the American Academy of Ophthalmology. EyeCare America is one of the country’s leading public service organizations, providing quality eye care with 90% of that care at no cost to qualified patients. He has also made two missions to Kurdistan, Northern Iraq where he had the privilege of treating local citizens and educating local doctors to bring more modern ophthalmic care to this underserved region. Dr. Labor considers those missions among his proudest accomplishments.
Certification and Association
- American Board of Ophthalmology
- American Board of Eye Surgery
Education
- Medical Degree- LSU School of Medicine
- Residency- The Eye Foundation Hospital/University of Alabama at Birmingham Combined Program
Call today to set up a consultation for EVO ICL
(817) 410-2030Select Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263.
6. Naves J.S, Carracedo G, Cacho-Babillo I, Diadenosine nucleotid measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
7. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
8. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
9. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
This provider locator tool is being provided by STAAR Surgical® Company (“STAAR”) solely to assist users in locating a provider who has experience with the EVO ICL family of lenses, as explained further here. Specifically, the sole criteria for inclusion in the locator is whether a provider is certified by STAAR to implant EVO ICL lenses. Users may search the locator by zip code, state, or current location. Two types of sorting functionality is available within the locator. Users are able to sort the results via distance, or by the frequency with which a healthcare provider has recently used EVO ICL lenses (e.g., within the past 12 months). Irrespective of the sorting method selected, all providers are shown in the results within the queried geographic location. The listed order of providers under any sorting method, including the initial presentation of providers in a geographic location, is based on a variety of factors, including whether the provider maintains consumer-facing information about EVO ICL lenses on its website, the breadth and quality of such information, whether it has demonstrated a commitment to training staff and offering the EVO ICL as a refractive procedure option to qualified patients, and how frequently the provider has performed procedures using the EVO ICL over the past year.
Notwithstanding the above, this provider locator tool should not be construed in any way as an endorsement or recommendation by STAAR as to the qualifications of any provider listed in this tool or the quality of medical care they can provide. STAAR makes no guarantees that using a provider from this list will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential provider. STAAR recommends that you meet and discuss the benefits and risks of the EVO ICL lens, and the procedure to implant the EVO ICL lens with the potential provider.
STAAR hereby disclaims any and all liability arising from your use of and/or reliance on the information contained in this provider locator tool.
Important Safety Information
The EVO Visian ICL Lens is intended for the correction of moderate to high nearsightedness. EVO Visian ICL and EVO Visian TICL surgery is intended to safely and effectively correct nearsightedness between -3.0 D to -15.0 D, the reduction in nearsightedness up to -20.0 D and treatment of astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before.
Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care professional. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts.
You should NOT have EVO Visian ICL surgery if:
- Your doctor determines that the shape of your eye is not an appropriate fit for the EVO Visian ICL
- You are pregnant or nursing
- You have moderate to severe damage to the optic nerve caused by increased pressure (glaucoma)
- You do not meet the minimum endothelial cell density for your age at the time of implantation as determined by your eye doctor
- Your vision is not stable as determined by your eye doctor
Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. For additional information with potential benefits, risks and complications please visit DiscoverICL.com.
Feeling unsure?
We get it. Decisions like this take time to consider and research. We can help guide your decision with information that's the most relevant to you.
Do you currently wear glasses or contacts?